thesis-toulmin
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q28067219-C63E239A-FA9B-4CF2-BCF6-B4590878DC80
Q28067219-C63E239A-FA9B-4CF2-BCF6-B4590878DC80
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28067219-C63E239A-FA9B-4CF2-BCF6-B4590878DC80
Targeting microenvironment in cancer therapeutics
P2860
Q28067219-C63E239A-FA9B-4CF2-BCF6-B4590878DC80
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28067219-C63E239A-FA9B-4CF2-BCF6-B4590878DC80
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9d73d083a2ca1a757fdff03c102bb0d5036da6f7
P2860
A phase I, open-label study of siltuximab, an anti-IL-6 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma, multiple myeloma, or Castleman disease.